Fibrin gel for controlled release of PDGF and uses thereof
US9012393B2 · kind B2 · utility
2Cited by
13References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 25, 2013 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Jun 29, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/414
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.